Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
resourceType | ValueSet |
id | 2.16.840.1.113883.3.464.1003.196.11.1216 |
canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1216 |
version | 20210914 |
status | active |
publisher | NCQA PHEMUR |
name | HepatitisBVaccine |
title | Hepatitis B Vaccine |
date | 2021-09-14T01:01:12-04:00 |
experimental | false |
Usages |
|
This value set contains 6 concepts
Code | System | Display |
08 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, pediatric or pediatric/adolescent dosage |
110 | http://hl7.org/fhir/sid/cvx | DTaP-hepatitis B and poliovirus vaccine |
146 | http://hl7.org/fhir/sid/cvx | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |
44 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, dialysis patient dosage |
45 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, unspecified formulation |
51 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b conjugate and Hepatitis B vaccine |
Produced 08 Sep 2023